Characteristics of Glucose Metabolism in Patients with Pituitary Growth Hormone Secreting Adenomas and the Impact of Trans?sphenoid Surgery
Min He,Yifei Yu,Meng Wang,Yeping Yang,Wei Gong,Ming Shen,Wenqiang He,Yongfei Wang,Yao Zhao,Hongying Ye,Yiming Li,Zhaoyun Zhang
DOI: https://doi.org/10.3760/cma.j.issn.1674-5809.2019.09.009
2019-01-01
Abstract:Objective To investigate the characteristics of glucose metabolism in patients with growth hormone (GH) secreting adenomas and the impact of trans?sphenoid surgery. Methods Preoperative and postoperative clinical information of patients with GH secreting adenomas who underwent trans?sphenoidal surgery in department of neurosurgery of Huashan Hospital from November 2011 to April 2016 were collected. Preoperative prevalence of abnormal glucose metabolism was analyzed; insulin resistance and β cell function were compared among different glucose tolerance groups; changes in the characteristics of glucose metabolism after operation were analyzed. Subgroup analysis was performed according to the recovery of GH and insulin?like growth factors?1 (IGF?1) after operation, and changes of glucose metabolism in different subgroups after operation were compared. Logistic regression analysis wasused to analyze the risk factors of glucose metabolism outcome after operation. Results A total of 81 patients were enrolled in this study. The preoperative prevalence of abnormal glucose metabolism was 69.1％(56/81). There was no difference in insulin resistance among normal glucose tolerance (NGT) group, pre?diabetes mellitus (preDM) group and diabetes mellitus (DM) group. Homeostasis medel assessment of insulin resistance [66.25(28.90, 129.76)％] and insulinogenesis index [2.24(1.34, 9.97)] in DM group were significantly lower than those in preDM group [195.30(141.00, 260.00)％, 32.65(8.56, 48.35), respectively] and NGT group [176.25(140.63, 218.14)％, 30.69(11.98, 51.38), respectively] (F=27.050, 20.690, both P<0.05). 67.9％(38/56) of patients with abnormal glycometabolism recovered to NGT after operation. Compared with pre?operation, glyacted hemoglobin (HbA1c) in complete remission group and GH remission group decreased significantly after operation [(6.4±1.5)％vs (5.7±0.7)％, (6.2±1.2)％vs (5.5±0.5)％, respectively, t=3.780, 3.378, both P<0.05], with no significant change in non?remission group. In the complete remission group, GH remission group and non?remission group there are 4, 3 and 2 indexes reflectingβ?cell function improved respectively. Logistic regression analysis showed that baseline HbA1c and biochemical remission state were correlated with the outcome of glucose metabolism after operation (all P<0.05). Conclusions Impairment of β cell function is the decisive factor for developing DM in patients with GH secreting adenomas. Preoperative HbA1c level and postoperative biochemical remission states affect the outcome of glucose metabolism after operation.